Randomized double blind placebo controlled multicentric clinical trial of Ayush M-3 in the management of migraine- A study protocol

The primary outcomes measures for the study will be changes in the character of disease in terms of frequency, intensity of headache as per VAS (0-10) and duration of episode of headache. Secondary outcome measure will be changes in MIDAS, MSQ2.1, changes in associated symptoms of migraine, change in the use of analgesics/symptom alleviating medication & Change in the required dose/withdrawal of Anti-hypertensive drugs if any. Assessment will be conducted on an interval of 28 days till 16 weeks and an intervention free follow up at the end of week 20.

Authors

Institutions

Publication Details

Journal
Journal of Ayurveda and Integrative Medicine
Published
2025-03-01
DOI
https://doi.org/10.1016/j.jaim.2024.101054
Primary Topic
Migraine and Headache Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Randomized double blind placebo controlled multicentric clinical trial of Ayush M-3 in the management of migraine- A study protocol

Bharti Bharti, K G Sudha Kumari, Rakesh Kumar Rana, B C S Rao et al.
Journal of Ayurveda and Integrative Medicine
Migraine and Headache Studies
article

Randomized double blind placebo controlled multicentric clinical trial of Ayush M-3 in the management of migraine- A study protocol

Bharti Bharti, K G Sudha Kumari, Rakesh Kumar Rana, B C S Rao, Renu Makhija, Richa Singhal, Sunita Mata, N Srikanth, Kartar Singh Dhiman, Shweta Chaudhary, Shruti Khanduri, Rabinarayan Acharya, Rajesh Kumar, Kuljeet Singh Anand, Bidhan Mahajan, Shweta Mata
article en

Abstract

The primary outcomes measures for the study will be changes in the character of disease in terms of frequency, intensity of headache as per VAS (0-10) and duration of episode of headache. Secondary outcome measure will be changes in MIDAS, MSQ2.1, changes in associated symptoms of migraine, change in the use of analgesics/symptom alleviating medication & Change in the required dose/withdrawal of Anti-hypertensive drugs if any. Assessment will be conducted on an interval of 28 days till 16 weeks and an intervention free follow up at the end of week 20.

Journal of Ayurveda and Integrative MedicineVol. 16(2)
Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital (IN), Central Council for Research in Ayurvedic Science (IN), Ministry of AYUSH (IN), CM Hospital (KR), Engineers India (India) (IN), National Institute of Mental Health and Neurosciences (IN), National Institute of Malaria Research (IN)
Ministry of AYUSH, Government of India
Openalex Percentile: Top 95%
Migraine and Headache Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.